Skip to main content
Alexi Wright, MD, Oncology, Boston, MA

Alexi Anne Wright MD MPH

Gynecologic Cancer, Hematologic Oncology


Associate Professor, Harvard Medical School Medical Oncologist, Dana-Farber Cancer Institute

Join to View Full Profile
  • 450 Brookline AveBoston, MA 02215

  • Phone+1 617-632-2334

  • Fax+1 617-632-3479

Dr. Wright is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2006 - 2009
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2006
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2003

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2005 - 2026
  • CT State Medical License
    CT State Medical License 2022 - 2025
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Dana-Farber Experts Present Innovative Cancer Studies at the 2025 AACR Annual Meeting
    Dana-Farber Experts Present Innovative Cancer Studies at the 2025 AACR Annual MeetingApril 26th, 2025
  • Dana-Farber Research Highlights Head and Neck, Breast, Lung, and Survivorship Studies at AACR Annual Meeting 2025
    Dana-Farber Research Highlights Head and Neck, Breast, Lung, and Survivorship Studies at AACR Annual Meeting 2025April 25th, 2025
  • Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors
    Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and DoctorsSeptember 10th, 2024
  • Join now to see all

Grant Support

  • A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
  • A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
  • A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
  • A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
  • A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
  • Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitorsDANA-FARBER CANCER INST2024–2029
  • BOLSTER: Strengthening Patient and Caregiver Supports in Advanced Gynecologic and Gastrointestinal Cancers - a Multi-Site Randomized Controlled TrialDANA-FARBER CANCER INST2023–2028
  • BOLSTER: Strengthening Patient and Caregiver Supports in Advanced Gynecologic and Gastrointestinal Cancers - a Multi-Site Randomized Controlled TrialDANA-FARBER CANCER INST2023–2028

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: